HRSA embeds EO 14168 restrictions in FY2026 grant terms and Ryan White HIV/AIDS Program funding opportunities

Funding action / Institutional complianceHRSA

Date
Actor
HRSA
Agency
Health Resources and Services Administration (HRSA)
Type
Funding action / Institutional compliance
Section
HEALTH AGENCIES (HHS, NIH, CDC, CMS, FDA, SAMHSA, HRSA, ACF)

Summary

HRSA's FY2026 General Terms and Conditions, its May 2026 "Strategic Priorities" statement, and 2026 Notices of Funding Opportunity for the Ryan White HIV/AIDS Program (ADAP Emergency Relief HRSA-26-012; Part B supplemental HRSA-26-074; Part C HRSA-26-061; Part F dental HRSA-26-085) incorporated EO 14168-derived restrictions on "gender ideology," which HIV clinicians allege bar or chill transgender-specific HIV prevention and care services in a program where transgender women are a priority population. The American Academy of HIV Medicine, HIVMA, IAPAC, and individual clinicians sued HRSA and HHS and moved for a preliminary injunction on June 10, 2026 (D. Mass. No. 1:26-cv-12638-WGY).

Status

Grant conditions in effect; preliminary-injunction motion filed June 10, 2026, with no ruling identified as of August 20, 2026. (See also sections 9, 10.) Update, Sept. 23, 2026: The case went to a bench trial, held Sept. 23, 2026 (D. Mass. No. 1:26-cv-12638); no decision had issued by that date.

As recorded in the data of . Check the sources for anything newer.

Related litigation

Documents

Sources